LXEO News and Press, Lexeo Therapeutics, Inc.

News Releases

LXEO News Releases

September 02, 2026 07:00:00 am

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

June 30, 2026 05:32:09 pm

LXEO : NASDAQ

SeekingAlpha

Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

June 22, 2026 08:30:34 am

LXEO : NASDAQ

SeekingAlpha

Lexeo Therapeutics's LX2006 Has A Viable Regulatory Pathway And Timeline

June 17, 2026 04:01:00 pm

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia

June 15, 2026 03:52:09 pm

LXEO : NASDAQ

SeekingAlpha

Lexeo Therapeutics, Inc. (LXEO) Shareholder/Analyst Call Transcript

June 15, 2026 07:00:00 am

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

May 19, 2026 07:00:00 am

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

May 11, 2026 08:30:07 am

LXEO : NASDAQ

SeekingAlpha

Lexeo Therapeutics GAAP EPS of -$0.25

May 11, 2026 07:00:00 am

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

April 27, 2026 05:15:00 pm

LXEO : NASDAQ

GlobeNewswire

Lexeo Therapeutics Announces Multiple Presentations at the 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

	Next 10

Lexeo Therapeutics, Inc. (NASDAQ : LXEO ) News

News Releases

Subscribe to Our Newsletter

Download The Market Wire News App

Schedule a 30 minute Brand Awareness meeting with Market Wire News

Link Market Wire News to Your X Account